Biocon Chief News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research-based incentives can boost the domestic pharmaceutical sector, making it worth USD 200 billion by 2030, according to Biocon Executive Chairperson Kiran Mazumdar-Shaw. She believes the industry has the potential to grow even further beyond the estimated USD 165 billion by 2030, but this growth must be driven by drug innovation rather than just generics and biosimilars. Mazumdar-Shaw emphasized the need for research incentives to drive this growth and called for stronger government support through research-linked incentive schemes. She also suggested decoupling private sector investment...

Mazumdar-Shaw shared a picture of her mother in remembrance and further wrote, “She has left a huge void.”

With Hindu organizations carrying out campaigns for boycotting Halal meat and the ruling BJP ministers openly endorsing it, the situation is turning ugly.

Kiran Mazumdar Shaw, Biocon Chief has issued a notification to Stock Exchanges in connection with her husband John Shaw's Offshore Trust. Kiran Mazumdar Shaw on Tuesday shared details on social media platform in this regard."Sharing my ...

Biocon's Kiran Mazumdar-Shaw has issued a notification to the Secretary, BSE limited and the Secretary, National Stock Exchange of India Limited on September 4, in a bid to rubbish the Pandora Papers allegations.